Michael Sapienza: Advancing Urgently Needed Research Through Project Cure CRC
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“The Colorectal Cancer Alliance is proud to continue advancing urgently needed research through Project Cure CRC.
We recently awarded over $1.3 million in new funding to five investigators leading cutting-edge work in colorectal cancer science. Grant recipients include researchers at the Olivia Newton-John Cancer Research Institute and La Trobe University, Indiana University School of Medicine, and The Johns Hopkins University.
With this latest round of grants, Project Cure CRC has invested $12.5 million in colorectal cancer research, supporting 29 studies to date. Each of these grants represents a deliberate and strategic effort to accelerate scientific progress where it’s most needed.
To learn more about Project Cure CRC, explore funding opportunities, or support the research driving real change, visit here.
For more information on the latest grants, read the press release here.”
More posts featuring Michael Sapienza.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023